Virus Diseases: all 927 studies
Page 9 of 10. Open to participants first (112), then studies with results posted, then the rest; newest registration first within each.
- Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionStatus unknownNCT01594905Phase 4
- A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus InfectionCompletedNCT01590654Phase 1
- DNA-based Influenza Vaccine in the ElderlyCompletedNCT01587131Phase 1
- Effects of Activity and Education Program on Patients With Chronic Hepatitis C InfectionStatus unknownNCT01572233Not applicable
- Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)CompletedNCT01567813
- Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected CellsCompletedNCT01546506Phase 2
- Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm InfantsCompletedNCT01545245
- Mepolizumab Treatment for Rhinovirus-induced Asthma ExacerbationsStatus unknownNCT01520051Phase 3
- Respiratory Viral Infection in Nursing Home SloveniaCompletedNCT01486160
- Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in ChinaCompletedNCT01459081Phase 3
- Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT01431898Phase 1
- Safety and Immunogenicity of an Inactivated EV71 Vaccine in InfantsCompletedNCT01421121Phase 2
- GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC GenotypeTerminatedNCT01384383Phase 2
- Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus InfectionCompletedNCT01371578Phase 2
- Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus InfectionCompletedNCT01347736Not applicable
- Treatment of Recently Acquired Hepatitis C Virus InfectionCompletedNCT01336010Phase 4
- A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT01316237Phase 1
- Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal TransplantStatus unknownNCT01289301Phase 4
- Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy ChildrenCompletedNCT01273246Phase 1
- Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy AdultsCompletedNCT01273233Phase 1
- Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 StudyCompletedNCT01251133Phase 3
- Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza VaccineCompletedNCT01244867Phase 2
- Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental ExposureNo longer availableNCT01206504
- The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health NeonatesCompletedNCT01183611Phase 3
- Epidemiology Of Respiratory Virus Infections In ChildrenCompletedNCT01167361
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BCompletedNCT01163240
- Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, TaiwanStatus unknownNCT01163123
- Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?CompletedNCT01159613
- The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in ChildrenStatus unknownNCT01159470
- Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal TransplantationCompletedNCT01136395Phase 2
- Avian Influenza Studies In LebanonCompletedNCT01107262
- A Study of Balapiravir in Patients With Dengue Virus InfectionCompletedNCT01096576Phase 1
- Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus InfectionCompletedNCT01090232Not applicable
- Comparison Between Dexchlorpheniramine and Dexchlorpheniramine/Pseudoephedrine/Guaifenesin in Respiratory InfectionsStatus unknownNCT01085721Phase 3
- A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus InfectionTerminatedNCT01080222Phase 2
- Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus InfectionCompletedNCT01072695Phase 2
- Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) PatientsWithdrawnNCT01062659
- Role of Cytokines in Hepatitis E Virus Infection During PregnancyCompletedNCT01062321
- Respiratory Virus Hospitalization Study (FLU 003 Plus)CompletedNCT01056185
- Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 PatientsStatus unknownNCT01055990Phase 2
- In UTERO Treatment of Cytomegalovirus Congenital Infection With ValacyclovirTerminatedNCT01037712Phase 4
- Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 InfectionCompletedNCT01032408Phase 3
- Immunogenicity of Off-Schedule Dosing of HPV VaccineCompletedNCT01030562
- Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and ChildrenCompletedNCT01021397Phase 1
- Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus InfectionStatus unknownNCT01001754Phase 2
- Evaluating an Ebola and a Marburg Vaccine in UgandaCompletedNCT00997607Phase 1
- Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy AdultsCompletedNCT00984945Phase 1
- Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young AdultsCompletedNCT00980447Phase 2
- Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and OlderCompletedNCT00975572Phase 2
- Norwalk Vaccine StudyCompletedNCT00973284Phase 1/2
- Hyperimmune Bovine Colostrum - TRAVELAN™ for Patients With Chronic Hepatitis C Virus Infection Not Responding to Standard TherapyWithdrawnNCT00956722Phase 1
- Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersTerminatedNCT00952185Not applicable
- Measuring Responses to Sublingual AntigensCompletedNCT00949572Not applicable
- Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis CCompletedNCT00948220Phase 4
- Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy AdultsCompletedNCT00921726Phase 1
- Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)WithdrawnNCT00895882Phase 2
- Virus Surveillance in Pediatric Solid Organ Transplant RecipientsStatus unknownNCT00886158
- Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus InfectionTerminatedNCT00874796Phase 2
- Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy AdultsCompletedNCT00853255Phase 1
- Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care UnitWithdrawnNCT00844155Not applicable
- A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis BStatus unknownNCT00815464Not applicable
- Rijavithi Viral and Mycobacterium PCR Arrays in CNS Infection StudyCompletedNCT00807378
- Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine VaccineCompletedNCT00734175Phase 1
- Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus VaccineCompletedNCT00722774Phase 1
- Safety and Immunogenicity Study of a Ross River Virus (RRV) VaccineCompletedNCT00717834Phase 1/2
- Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector InjectionCompletedNCT00709605Phase 1
- Safety Study of HBV-002 West Nile Vaccine in Healthy AdultsCompletedNCT00707642Phase 1
- Surveillance Study of Viral Infections Following Lung TransplantationCompletedNCT00701922
- Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver TransplantationCompletedNCT00668369Phase 2
- Prospective Surveillance For Respiratory Virus Infections In Children Undergoing Hematopoietic Stem Cell TransplantationCompletedNCT00667303
- Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus VaccineCompletedNCT00641017Phase 1
- FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral TherapyCompletedNCT00606528
- Ebola and Marburg Virus VaccinesCompletedNCT00605514Phase 1
- Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian ChildrenCompletedNCT00585481
- Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic SyndromeCompletedNCT00577525
- Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT00565539Phase 1
- A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)CompletedNCT00551915Phase 2
- A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)CompletedNCT00551629Phase 2
- Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in TaiwanStatus unknownNCT00543244
- Influenza in People With Normal and Weakened Immune SystemsCompletedNCT00533182
- Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy AdultsCompletedNCT00516035Phase 1
- Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.CompletedNCT00502086Phase 3
- Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given IntradermallyCompletedNCT00489931Phase 1
- Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsCompletedNCT00488046Phase 1
- Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsCompletedNCT00448604
- ZOSTAVAX(R) Local Registration Trial (V211-019)CompletedNCT00444860Phase 3
- Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody TherapyCompletedNCT00420966
- Safety Study of Avian Flu VaccineCompletedNCT00408109Phase 1
- Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.CompletedNCT00383864Phase 4
- Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)CompletedNCT00380237Phase 1
- Experimental Vaccine for Prevention of Ebola Virus InfectionCompletedNCT00374309Phase 1
- Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and AdultsCompletedNCT00366782Phase 1
- Identification of Viruses Associated With Diseases of Unknown CauseTerminatedNCT00359268
- Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsCompletedNCT00347672Phase 1
- Pharmacokinetic Study Of Valaciclovir Hydrochloride TabletsCompletedNCT00343278Phase 4
- Specimens From Normal ControlsCompletedNCT00341211
- Validation of Self-Reported Needle Sharing Among Injection Drug UsersCompletedNCT00341081
- Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy InfantsCompletedNCT00308412Phase 1
- An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution SyndromeCompletedNCT00294918Phase 2/3
- Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)CompletedNCT00294164Phase 2/3